Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis

Immunity

Volumn 19, Issue 3, 2003, Pages 317-328

  Bynoe, Margaret S ^a   Evans, J Tori ^a   Viret, Christophe ^a   Janeway Jr , Charles A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AC1 11 PROTEIN; AUTOANTIGEN; CD4 ANTIGEN; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; MOG 35 55; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE; PERTUSSIS TOXIN; PLP 139 151; PROTEOLIPID PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BRAIN; CELL ACTIVATION; CELL COMMUNICATION; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENT; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RECIPIENT; RELAPSE; REMISSION; SUPPRESSOR CELL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0141678964     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00239-5     Document Type: Article

References (36)

1. Annacker O., Burlen-Defranoux O., Pimenta-Araujo R., Cumano A., Bandeira A. Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment. J. Immunol. 164:2000;3573-3580.
2. Apostolou I., Sarukhan A., Klein L., von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3:2002;756-763.
3. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Jr. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
4. Brabb T., von Dassow P., Ordonez N., Schnabel B., Duke B., Goverman J. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J. Exp. Med. 192:2000;871-880.
5. Brosnan C.F., Raine C.S. Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6:1996;243-257.
6. Chai J.G., Bartok I., Chandler P., Vendetti S., Antoniou A., Dyson J., Lechler R. Anergic T cells act as suppressor cells in vitro and in vivo. Eur. J. Immunol. 29:1999;686-692.
7. Cumberbatch M., Dearman R.J., Griffiths C.E., Kimber I. Langerhans cell migration. Clin. Exp. Dermatol. 25:2000;413-418.
8. Dittel B.N., Urbania T.H., Janeway C.A. Jr. Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice. J. Autoimmun. 14:2000;311-318.
9. Gershon R.K., Kondo K. Infectious immunological tolerance. Immunology. 21:1971;903-914.
10. Goverman J. Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein. Immunol. Rev. 169:1999;147-159.
11. Goverman J., Brabb T. Rodent models of experimental allergic encephalomyelitis applied to the study of multiple sclerosis. Lab. Anim. Sci. 46:1996;482-492.
12. Hardardottir F., Baron J.L., Janeway C.A. Jr. T cells with two functional antigen-specific receptors. Proc. Natl. Acad. Sci. USA. 92:1995;354-358.
13. Herrick C.A., MacLeod H., Glusac E., Tigelaar R.E., Bottomly K. Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J. Clin. Invest. 105:2000;765-775.
14. Hu S.K., Eardley D.D., Cantor H., Gershon R.K. Definition of two pathways for generation of suppressor T-cell activity. Proc. Natl. Acad. Sci. USA. 80:1983;3779-3781.
15. Karandikar N.J., Vanderlugt C.L., Eagar T., Tan L., Bluestone J.A., Miller S.D. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J. Immunol. 161:1998;192-199.
16. King C., Sarvetnick N. Organ-specific autoimmunity. Curr. Opin. Immunol. 9:1997;863-871.
17. Kuchroo V.K., Anderson A.C., Waldner H., Munder M., Bettelli E., Nicholson L.B. T cell response in experimental autoimmune encephalomyelitis (EAE). role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire Annu. Rev. Immunol. 20:2002;101-123.
18. Lafaille J.J., Nagashima K., Katsuki M., Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell. 78:1994;399-408.
19. Lechler R., Chai J.G., Marelli-Berg F., Lombardi G. The contributions of T-cell anergy to peripheral T-cell tolerance. Immunology. 103:2001;262-269.
20. Linsley P.S., Ledbetter J.A. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:1993;191-212.
21. Olivares-Villagomez D., Wang Y., Lafaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 188:1998;1883-1894.
22. Olivares-Villagomez D., Wensky A.K., Wang Y., Lafaille J.J. Repertoire requirements of CD4+ T cells that prevent spontaneous autoimmune encephalomyelitis. J. Immunol. 164:2000;5499-5507.
23. Ptak W., Gershon R.K., Flood P.M. Mechanisms of suppression in the transfer of contact sensitivity. Analysis of an I-J+ molecule required for Ly2 suppressor cell activity. J. Exp. Med. 158:1983;1822-1835.
24. Ragazzo J.L., Ozaki M.E., Karlsson L., Peterson P.A., Webb S.R. Costimulation via lymphocyte function-associated antigen 1 in the absence of CD28 ligation promotes anergy of naive CD4+ T cells. Proc. Natl. Acad. Sci. USA. 98:2001;241-246.
25. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1995;1151-1164.
26. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:2000;431-440.
27. Shevach E.M. Certified professionals. CD4(+)CD25(+) suppressor T cells J. Exp. Med. 193:2001;F41-F46.
28. Steinman L. Multiple sclerosis. a two-stage disease Nat. Immunol. 2:2001;762-764.
29. Stephens L.A., Mason D. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. J. Immunol. 165:2000;3105-3110.
30. Thorstenson K.M., Khoruts A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167:2001;188-195.
31. Van de Keere F., Tonegawa S. CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J. Exp. Med. 188:1998;1875-1882.
32. Wang L.F., Lin J.Y., Hsieh K.H., Lin R.H. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J. Immunol. 156:1996;4077-4082.
33. Wang L.F., Sun C.C., Wu J.T., Lin R.H. Epicutaneous administration of hapten through patch application augments TH2 responses which can downregulate the elicitation of murine contact hypersensitivity. Clin. Exp. Allergy. 29:1999;271-279.
34. Weiner H.L. Oral tolerance. immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells Microbes Infect. 3:2001;947-954.
35. Wulfing C., Davis M.M. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science. 282:1998;2266-2269.
36. Zhang X., Izikson L., Liu L., Weiner H.L. Activation of cd25(+)cd4(+) regulatory t cells by oral antigen administration. J. Immunol. 167:2001;4245-4253.